Viral hepatitis is a global health problem that affects hundreds of millions of children and adults. Although multiple pathogens have been associated with hepatitis, three in particular (Hepatitis A, B, and C) are responsible for the majority of virally linked hepatitis cases. Chronic viral hepatitis B and C are a major cause of chronic liver disease which may manifest as liver fibrosis and cirrhosis leading to liver cancer and the need for liver transplantation.
Learn about chronic liver disease and liver fibrosis.
Siemens delivers a comprehensive hepatitis disease management portfolio to provide crucial serologic test results with excellent sensitivity and specificity, minimizing the need for repeat confirmatory testing. Our molecular diagnostic viral load monitoring and genotyping assays provide physicians with critical information that aids in optimizing treatment decisions.
Hepatitis assays available from Siemens:
ADVIA Centaur® Systems
BEP® III and BEP 2000 Advance® Systems 1
HBsAg Confirmatory Test
Quadriga BeFree® System1
Molecular Diagnostic Assays
VERSANT HCV RNA 1.0 Assay (kPCR)
VERSANT HBV DNA 1.0 Assay (kPCR)
VERSANT HCV Genotype 2.0 Assay(LiPA)4
1. Not available in U.S.
2. In development
3. Not available on IMMULITE® 1000
4. CE Marked. For research use only
† Assay developed, manufactured and sold by Siemens Healthcare Diagnostics Inc. for Ortho-Clinical Diagnostics, Inc.
Not all assays are available in all countries due to varying regulatory requirements. Product availability varies from country to country and is subject to change without notice. Contact your local Siemens Healthcare Diagnostics representative for information.
Bu web sayfasında gösterilen ürünler/özellikler her ülkede piyasada bulunmamaktadır. Mevzuata bağlı nedenlerle gelecekte bulunabileceği garanti edilemez. Lütfen daha fazla bilgi için yerel Siemens organizasyonuyla iletişime geçiniz.